Dr. Safdar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6445 Main Street
OPC 22
Houston, TX 77030Phone+1 713-441-7182Fax+1 713-796-1701- Is this information wrong?
Summary
- Director, Pulmonary Hypertension Care Center.
Director, Pulmonary Fibrosis Center
Interim Director, Houston Methodist Lung Center
Education & Training
- Baylor college of medicineMS, Maters in Clinical Investigation, 2008 - 2015
- New York-Presbyterian HospitalPost-Doctoral Fellowship, Lung Biology Lab, 2001 - 2005
- Icahn School of Medicine at Mount Sinai/Morningside/WestFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2003
- Icahn School of Medicine at Mount Sinai/Morningside/WestFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2001
- SUNY Health Science Center at BrooklynResidency, Internal Medicine, 1995 - 1998
- Eastern Virginia Medical SchoolInternship, Preliminary Year, 1994 - 1995
- Sind Medical CollegeClass of 1991
Certifications & Licensure
- TX State Medical License 2006 - 2025
- NY State Medical License 1998 - 2010
- NJ State Medical License 2003 - 2005
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- Baylor college of medicineMaster of Clinical Sciences
Awards, Honors, & Recognition
- Educational Leadership Fulbright & Jaworki Award, 2012
- Teaching and Evaluation Fulbright & Jaworski Award, 2011
- Academy of Distinguished Educators Baylor College of Medicine, 2011
- Join now to see all
Clinical Trials
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
- Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial Start of enrollment: 2010 Mar 01
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies.Kim, N., MacDonald, G., Martin, N., Rosenberg, D., Solonets, M., Chin, K., McLaughlin, V., DuBrock, H., Restrepo-Jaramillo, R., Safdar, Z., Channick, R.> ;Pulmonary Therapy. 2024 Mar 1
- Pulmonary Hypertension in Women.Eunwoo Park, Zeenat Safdar> ;Methodist Debakey Cardiovascular Journal. 2024 Jan 1
- 5 citationsIntegrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.Peifeng Ruan, Jamie L Todd, Hongyu Zhao, Yi Liu, Richard Vinisko, Julia F Soellner, Ramona Schmid, Robert J Kaner, Tracy R Luckhardt, Megan L Neely, Imre Noth, Mary Po...> ;Respiratory Research. 2023 May 31
- Join now to see all
Press Mentions
- Deadly Vaping Illnesses Linked to THC ProductsSeptember 27th, 2019
- 8 Deaths, 530 Illnesses from Vaping: Here’s What to KnowSeptember 23rd, 2019
- Houstonians’ Say Their Allergies Are Horrible, but Doctors Think They Know What’s to BlameOctober 15th, 2017
- Join now to see all
Grant Support
- Effect Of Spironolactone Of Collagen Synthesis In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2010–2011
Committees
- Chair, Pulmonary Hypertension Association Online University 2013 - 2015
- National Chair, PHA on the Road 2013 - 2015
- Chair, Young Council - Pulmonary vascular research institute 2013 - 2015
Professional Memberships
- Fellow
- Fellow
- Fellow
- Pulmonary Vascular Research InstituteMember
Hospital Affiliations
- St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
- Houston Methodist HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: